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  24 
Abstract  25 
Last year ActinoBase, a Wiki-style initiative supported by the UK Microbiology Society, published a review 26 
highlighting the research of particular interest to the actinomycete community. Here, we present the 27 
second ActinoBase review showcasing selected reports published in 2020 and early 2021, integrating 28 
perspectives in the actinomycete field.  29 
Actinomycetes are well-known for their unsurpassed ability to produce specialised metabolites, of which 30 
many are used as therapeutic agents with antibacterial, antifungal, or immunosuppressive activities. 31 
Much research is carried out to understand the purpose of these metabolites in the environment, either 32 
within communities or in host interactions. Moreover, many efforts have been placed in developing 33 
computational tools to handle big data, simplify experimental design, and find new biosynthetic gene 34 
cluster prioritisation strategies. Alongside, synthetic biology has provided advances in tools to elucidate 35 
the biosynthesis of these metabolites. Additionally, there are still mysteries to be uncovered in 36 
understanding the fundamentals of filamentous actinomycetes' developmental cycle and regulation of 37 
their metabolism. 38 
This review focuses on research using integrative methodologies and approaches to understand the bigger 39 
picture of actinomycete biology, covering four research areas: i) technology and methodology; ii) 40 
specialised metabolites; iii) development and regulation; and iv) ecology and host interactions. 41 
Keywords: ActinoBase; Actinobacteria; development; integrating perspectives; methodology; microbial 42 
ecology; natural products; regulation; specialised metabolites; Streptomyces.  43 
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  63 
Introduction  64 
ActinoBase (https://actinobase.org) was established in 2019 with the support of the UK Microbiology 65 
Society as a Wiki-style initiative for the actinomycete research community. It aims to create a communal 66 
space to distribute knowledge and resources. Last year, ActinoBase published a review highlighting ten 67 
publications of important contributions to the field from 2019 [1]. This second review showcases 14 68 
articles that integrate perspectives in actinomycete research from 2020 and early 2021, covering four 69 
main areas: i) technology and methodology; ii) specialised metabolites; iii) development and regulation; 70 
and iv) ecology and host interactions (Figure 1). 71 
Actinobacteria are Gram-positive high GC content bacteria, with a diverse range of morphologies ranging 72 
from unicellular cocci or rods to multicellular filamentous hyphae and spore-forming organisms 73 
depending on their genera [2]. They are widely distributed across ecosystems, ubiquitous in soil and water 74 
habitats, and can live in symbiosis with higher eukaryotes [3]. A striking feature of actinomycete is that 75 
they produce chemically diverse specialised metabolites (SMs). SMs are compounds not essential for 76 
maintenance and growth, but often play a critical role in interspecies interactions [4]. Additionally, many 77 
SMs are of therapeutical value [5], constituting a rich resource for drug discovery [6]. SMs are often 78 
referred to as natural products (NPs) as well, this wider term encompasses any compound made by a 79 
living organism. Due to the current antimicrobial crisis, there is a need to improve the finding of novel 80 
antibiotics from actinomycetes, by developing advances in the detection/production pipeline, and 81 
applying integrative approaches to unveil SMs function [7]. For instance, SMs production in Streptomyces 82 
is linked to its life cycle [8–10], highlighting the importance of understanding its complex developmental 83 
regulation [11].  84 
SMs are genetically encoded small molecules produced by a group of co-occurring genes referred to as 85 
biosynthetic gene clusters (BGCs), involved in synthesising one or more structurally-similar molecules [5, 86 
12]. The genomic era has opened a new roadmap for the study of BGCs with genome mining as a 87 
prominent strategy to find candidates for novel bioactive compounds [4, 13, 14]. This has allowed 88 
researchers to uncover thousands of new BGCs of different classes, including polyketides (PKs); non-89 
ribosomal peptides (NRPs) [15–18]; PK-NRP hybrid compounds; ribosomally synthesized and post-90 
translationally modified peptides (RiPPs) such as lanthipeptides or thiopeptides [19–21]; and volatile 91 
organic compounds (VOCs) [22, 23]; among others [24–28].  92 
Although genomics has revealed key elements of SMs biosynthesis, there are still challenges to overcome. 93 
Their low production,  the rediscovery of known compounds, and a general lack of understanding of the 94 
role of these compounds in nature, as well as the fact that many organism remain unculturable [29, 30]. 95 
Moreover, many computational tools for high-throughput data mining have been developed to support 96 
BGCs prioritisation and dereplication [31]. Handling big data requires prioritisation to establish selection 97 
criteria for certain BGCS based on the specific research context. [32]. Dereplication is selecting a BGCS 98 
based on its novelty, often achieved by comparing with databases such as Minimum Information about a 99 
Biosynthetic Gene Cluster (MIBiG) [33, 34].  100 
Additionally, advances in synthetic biology have improved the genetic manipulation of actinomycetes, 101 
helping to characterize and functionally validate BGCs predictions [35–37]. Furthermore, engineering 102 
BGCs has been crucial to unlocking their potential since most BGCs are silent or cryptic under controlled 103 
laboratory conditions [38]. Recent definitions for cryptic and silent BGCS describe cryptic as a BGCS where 104 
the compound is unknown, but its biosynthesis is not; and silent as the compound is undetectable [38]. 105 
In this context, understanding actinomycete relationships with the environment and other organisms is a 106 
crucial factor when searching for BGCs elicitors, referred to as molecules or signals that can trigger the 107 
expression of a certain BGCs [11].  108 
Currently, integrative approaches are used to fill these knowledge gaps, which ultimately deepen our 109 
understanding of actinomycete biology. This trend is the central theme of this review, which highlights 110 
recent studies from 2020 and early 2021 that integrated genomic, metabolomic, transcriptomic, genetic 111 
engineering, and ecological data to provide significant insights in actinomycete research. (Figure 1).  112 
I. Technology and Methodology 113 
Stagnation in the traditional SMs discovery pipeline has motivated researchers to develop novel strategies 114 
for compound discovery [7]. The boost in sequencing has guided genome-based predictions of BGCs with 115 
tools such as antiSMASH for BGCs classification, according to their core enzymes [39]. Similarly, PRISM 116 
[40], BAGEL [41] or RiPPMiner [42] are complementary mining tools, and a complete list is available here 117 
http://www.secondarymetabolites.org/mining/. Development of community resources such as MIBiG 118 
repository have been essential for deposit functionally characterised BGCs data in a standardised manner 119 
[34]. A continuous challenge is to interpret BGCs in terms of their novelty and function, for which tools 120 
facilitating their comparison applied to large data sets have invigorated clinically relevant SMs discovery. 121 
Two of these recent tools, BiG-SCAPE [43] and Global Natural Product Social Molecular Networking (GNPS) 122 
[44], enable building of interactive similarity networks of BGCs and SMs, respectively. While grouping of 123 
BGCs is according to sequence similarity, the grouping of SMs is by mass spectrometry fragmentation 124 
patterns (MS/MS). In the past year, these tools have been expanded by the release of BiG-SLiCE [8], BiG-125 
FAM [45] and Qemistree [46], allowing further refinement of big data exploration, which we have selected 126 
to address in detail below. A comprehensive general review of the latest bioinformatics development is 127 
also offered in Medema (2021) [47]. 128 
In parallel, the field has encountered important methodological advances in synthetic biology. This 129 
complementary approach is simplifying the experimental testing of the hypotheses derived from 130 
computational predictions. Actinomycete are often hard to genetically manipulate: some exhibit low 131 
intrinsic recombination frequencies, are slow-growers, or fail to sporulate; thus, many efforts go to 132 
delivering or adapting new tools for their genetic manipulation [48]. Traditionally PCR based technologies 133 
such as ReDIRECT [49] have been complemented or replaced by other methods such as the meganuclease 134 
I-SceI from Saccharomyces cerevisiae [50] for the use in novel and genetically uncharacterised 135 
actinomycete; the adaptation of the CRISPR-Cas9 system through the development of pCRISPomyces [36]; 136 
and more recently to the CRISPR-BEST system [51], which allows genome manipulation without the 137 
introduction of a double-strand break, highlighted in last year’s ActinoBase review [1].  138 
Another challenge in metabolic engineering is that engineered strains frequently become less fit due to 139 
unforeseen metabolic constraints and imbalances, necessitating individual and optimisation for each 140 
strain and heterologous cloned BGC. Thus, the characterisation of new biosynthetic pathways becomes a 141 
very time consuming and laborious process when testing expression in different heterologous hosts. A 142 
detailed review focussing on synthetic biology advances in Streptomyces can be found at Breitling et al. 143 
[37].  144 
To have a toolbox of entirely synthetic systems controllable for each subclass of BGCs would allow a more 145 
streamlined screening of the large amount of cryptic and silent gene clusters that we observe in the in 146 
silico analyses [52]. We have chosen to highlight two articles with important advances in these topics: an 147 
optimised cell-free transcription-translation one-pot reaction that circumvents heterologous hosts' 148 
incompatibility and bring us a step closer to the above-mentioned synthetic biology toolbox [54]; and the 149 
combination of a quorum-sensing mechanism inside a CRISPRi circuit, allowing a dynamic metabolic 150 
engineering approach [53]. 151 
 152 
BiG-SLiCE: A highly scalable tool maps the diversity of 1.2 million biosynthetic gene clusters [8]  153 
One approach to understanding the vast diversity and taxonomic distribution of BGCs is through their 154 
comparative study. Homologous BGCs are hypothesized to produce similar SMs, which can be grouped 155 
based on sequence similarity into gene cluster families (GCFs). The first tool to accomplish this was BiG-156 
SCAPE which allowed calculation of pairwise distances between BGCs and mapped them onto interactive 157 
sequence similarity networks [43]. However, the amount of computing power required by this algorithm 158 
was a drawback to scale up from thousands to millions of BGCs. To address this problem, BiG-SLiCE was 159 
developed [8]. In contrast to the detailed BiG-SCAPE classification, BiG-SLiCE manages big data by 160 
representing BGCs in the Euclidean space, grouping them in non-linear and non-pairwise fashion. In this 161 
way, this powerful clustering platform manages to roughly organise 1,225,071 BGCs from genomes and 162 
metagenome-assembled genomes (MAGs) in just ten days.  163 
 164 
BiG-SLiCE operates by finding a set of 121,299 BGCs as centres of GCFs after the first round of clustering, 165 
assigning BGCs to its corresponding family by considering the minimal distance to these centroids. For 166 
centroids determination, BiG-SLiCE firstly encodes BGCs into a numerical vector capturing the presence 167 
of selected domains from a curated set of Hidden Markov Models (HMM) from the Pfam database [54]. 168 
Subsequently, the BIRCH superlinear clustering algorithm is applied to these numerical vectors to define 169 
family profiles [55], and the average vector of the cluster will be determined as the centroid. Centroids 170 
are then directed to the second round of clustering, using the K-mean algorithm to allow visualisation in 171 
a species tree [56]. As a result, families are grouped into 500 bigger sets called bins. Afterwards, every 172 
BGC is mapped to the closest centroid of these bins and are further classified. Finally, SQLite is used to 173 
store this data and allow new BGCs searches (https://www.sqlite.org/index.html), while R and python 174 
scripts are provided as visualisation tools. 175 
 176 
For the first time, a global map of biosynthetic diversity was created thanks to BiG-SLiCE: 121,299 177 
centroids from the first round of clustering were grouped into 500 bins, and finally, 1.2 million BGCs were 178 
mapped onto these. The 500 bins are displayed in a hierarchical tree allowing exploration of their 179 
distribution across different taxa. While Streptomyces confirms its status among the genera with the 180 
greatest BGCs potential, other members of Actinobacteria and Ascomycota, Firmicutes, and 181 
Proteobacteria phyla also appear among those bearing important biosynthetic potential. BiG-SLiCE also 182 
estimates that only 3.7% of the GCFs are closely related to the characterised MIBiG BGCs, highlighting the 183 
unknown chemistry that remains uncovered. Another advantage of BiG-SLiCE is that it allows to rapidly 184 
locate a new BGCs of interest via a simple search mode in the pre-calculated families stored in the BiG-185 
FAM database. 186 
 187 
Although BiG-SLiCE was developed to reveal the uncharted biosynthetic potential, it is based solely on 188 
antiSMASH-predicted BGCs, and a selection of biosynthetic Pfam domains was used for the construction 189 
of the GCFs models. Consequently, genomic vicinities predicted by other algorithms, or BGCs lacking the 190 
specifically selected domains, would be left out of the analysis. Hopefully, this will improve in the future. 191 
Moreover, due to gene content or sequence variation, each GCF may be subdivided into subsets of BGCs 192 
that produce different metabolites. The number of different products by family may differ as well as the 193 
genetic variation rate. A remaining challenge is to incorporate different thresholds to integrate each 194 
family, considering the chemical variation of its produced metabolites. 195 
 196 
BiG-FAM: the biosynthetic gene cluster families database [45] 197 
The increasing availability of BGCs data created the problem of understanding their diversity on a new 198 
computational scale. Specific BGCs databases, such as antiSMASH-DB [57] and IMG-ABC [58], can display 199 
similarity to the MIBiG repository. However, they do not consider a metric of distance to homologous 200 
BGCs conforming GCFs. Thus, there was a lack of a BGCs family database, now fulfilled by the development 201 
of BiG-FAM [45]. While BiG-SLiCE solved the problem of defining a metric and algorithm in feasible 202 
computational time that allow the classification of the millions of currently available BGCs into GCFs, the 203 
BiG-FAM database acts as a repository to display BiG-SLiCE results.  204 
 205 
In BiG-FAM, SQL is used to provide fast searches (i.e., 0.5 seconds) from BiG-SLiCE pre-calculated families, 206 
while Python/R scripts and flask libraries (Python-based web framework) provide a user-friendly interface. 207 
BiG-FAM goes beyond a storage and consulting website, as it allows exploring taxonomic distributions by 208 
including a web-based query function for users to match their own antiSMASH predicted BGCs onto GCFs, 209 
which reveals the closest and distant relatives of the queried BGCs. Meaning that a BGC of interest, not 210 
included in the BiG-SLiCE calculation, could easily be situated in BiG-FAM families without the necessity 211 
of calculating the distance between the BGC of interest and every other BGC represented in BiG-FAM. 212 
Subsequently, BiG-SLiCE can calculate the closest centroid and finally, classify the BGC of interest into the 213 
corresponding family. Another advantage of BiG-FAM it includes functionally characterised BGCs from 214 
MIBiG, accessible by either using a taxonomy search or other filters of interest. The BiG-FAM result is 215 
displayed as an interactive platform by providing graphic visualisation of Pfam domains within each gene 216 
and creating a word cloud to show the abundance of these domains.  217 
 218 
Authors showcase BiG-FAM with two examples. First, a ranthipeptide (i.e., radical non-α thioether 219 
containing peptides) RiPP BGCs diversity was explored, where ranthipeptide genetic neighbourhood and 220 
the precursors needed for its biosynthesis were discovered using a comparative visualisation. Secondly, 221 
BGCs assignment into GCFs from a newly sequenced Streptomyces strain was carried out, and the novelty 222 
of ‘Region 15.1’ BGC was explored by localizing its family. Using ClusterBlast, this BGC showed low levels 223 
of similarity against public databases, consistent with BiG-FAM results, which showed it as a singleton.  224 
 225 
BiG-FAM allows similarity searches by adding of another layer of comparison, such as domain architecture, 226 
which can add knowledge into more distant BGCs relationships. It can explore homologous BGCs as 227 
families and furthermore, it can place BGC of interest within these families. BiG-FAM opens the door to 228 
address questions regarding the composition and variation within these families, and their analysis 229 
regarding conservation. Nevertheless, as BiG-FAM is not a BGCs database, it does not provide BGC specific 230 
details, only family information. Pre-calculation and previous knowledge are required to define 231 
parameters such as the minimum set of domains that allow vectorization of BiG-SLiCE, and it can be a 232 
drawback when analysing underrepresented clades, such as Archaea, which genomes are one order of 233 
magnitude below other domains. Thus, results might be biased towards overrepresented groups.  234 
 235 
An important issue that remains for future work is to understand how to apply these algorithms to other 236 
biological processes involving gene clusters, such as operons from central metabolism or unknown BGC 237 
classes. The ability to classify and map processes other than specialised metabolism in this way would 238 
increase our understanding of specialised metabolite producers. Additionally, metadata such as 239 
geographic or ecological distribution of the BGCs families could be incorporated into the database, as it 240 
could help answer evolutionary, genomic, and ecological questions regarding BGCs.  241 
 242 
Chemically informed analyses of metabolomics mass spectrometry data with Qemistree [46] 243 
 244 
While BiG-SLiCE and BiG-FAM rely on genomic input, metabolomics has also encountered the necessity 245 
to develop tools to access big data to extract meaningful information. For instance, GNPS molecular 246 
networking [44] allows MS/MS comparison to visualise their relations in discrete molecular families (MFs). 247 
In contrast to classical molecular networking, Qemistree enables exploring the relatedness of all features 248 
in the dataset. Qemistree is a tree-based metabolomics visualisation tool for tandem MS data from 249 
untargeted metabolomics experiments, hierarchically representing chemical features, analogous to 250 
phylogenetic tree building for sequences. 251 
The pipeline utilises chemical feature detection [59] followed by SIRIUS [60, 61] to determine each 252 
feature's molecular formula, and using the fragmentation pattern to estimate the best fragmentation 253 
tree. In the next step, CSI: FingerID [62] uses those fragmentation trees and kernel support vector 254 
machines to predict molecular properties resulting in molecular fingerprints. Pairwise distances are then 255 
calculated and hierarchically clustered to generate a tree representing structural relationships. Finally, 256 
ClassyFire [63] can assign chemical taxonomy and iTOL acts as a visualisation tool for the resulting tree 257 
[64]. The software pipeline is freely available either as a QIIME2 plugin [65] or GNPS networking flow [66].   258 
The authors utilise three different approaches to evaluate the tool by case studies. The first one attempts 259 
to demonstrate Qemistree's advantage over traditional analysis tools relying on molecular fingerprints, 260 
independent of retention time shifts that could result from differing elution conditions. The second one 261 
shows that the tree-based analysis using chemical relatedness can detect similarities among different 262 
samples, where traditional methods often lead to an over-assumption of differences. Last, a 263 
heterogeneous dataset was obtained, showing that the chemical features agreed with ClassyFire, 264 
confirming that molecular fingerprints are a suitable marker.  265 
Qemistree relies on molecular fingerprints and their prediction is limited to the quality and coverage 266 
available in MS/MS spectral databases. In the future, it will be interesting if the concept of Qemistree can 267 
be applied on other chemical relationship markers such as chemical classes, spectral motifs and shared 268 
biosynthetic origins, however this will require further benchmarking to assess when to use which 269 
approach.  270 
Overall, Qemistree is universally applicable and a readily available tool to interpret and visualize complex 271 
metabolomics data. As GNPS is already widely used in the actinomycete community, this additional 272 
feature in the pipeline will be of value to compare samples from different taxa and/or environments to 273 
discover novel chemical diversity and aid dereplication challenges at a large scale, like the Earth 274 
Microbiome project [67]. Moreover, it adds another layer of understanding, taking into consideration 275 
molecular relatedness in addition to the genetic one. 276 
A Streptomyces venezuelae Cell-Free Toolkit for Synthetic Biology [68] 277 
Cell-free systems are powerful tools in synthetic biology, allowing a controlled and simplified environment 278 
to study specific cellular processes in the absence of the entirety and complexities of cells [69]. Due to 279 
mostly unknown regulatory circuits for silent BGCs, cell-free systems stand as an attractive and fast wet-280 
lab option to test hypotheses derived from computational predictions. 281 
Moore et al. introduce an optimised cell-free transcription-translation (TX-TL) system tailored for studying 282 
Streptomyces silent metabolic pathways. Cell-free TX-TL systems are crude cell extracts (or purified 283 
ribosomes) containing translation factors and the respective DNA coding for the pathway of interest on a 284 
plasmid in a buffered solution. Thus, it allows a quick and inexpensive way of studying transcription, 285 
translation and biosynthesis in a “one-pot” reaction [70–72]. It offers a simplified and controllable 286 
environment to study SMs by providing precursors for biosynthesis and direct control over feeding 287 
precursors in short experimental time scales. Moreover, it is crucial for circumventing unknown regulatory 288 
cascades by providing the genes of interest on a plasmid under the control of a chosen promoter.  289 
A robust, high-yield Streptomyces TX-TL protocol is achieved by optimising temperature; pH; regulatory 290 
elements (i.e., promoter strength, start codon preference, terminator); energy solution (i.e., NTP 291 
concentration); ATP regeneration (i.e., secondary energy sources); RNase inhibition (i.e., polyvinyl sulfonic 292 
acid (PVSA) concentration); DNA concentration and methylation, yielding at least 6-fold improvement to 293 
the previous system with fewer batch variations. 294 
Protein expression yields were assessed by codon optimised expression of genes for sfGFP, mVenus and 295 
mScarlet as reporters using real-time detection, as well as the expression of the oxytetracyline enzymes 296 
(otc cluster) from S. rimosus, and three NRPS genes (txtA and txtB from S. scabiei; and an unknown NRPS 297 
from S. rimosus). Furthermore, they also studied the expression using a codon optimised GUS reporter 298 
and two pathways from S. venezuelae DSM-40230: the copper metallochaperone (MelC1) and tyrosinase 299 
(TyrC) from the melanin pathway, as well as the early-stage haem pathway (HemB, HemD-CysG, HemC). 300 
In both cases, the TX-TL systems supported transcription, translation, and biosynthesis, as they observed 301 
the brown pigment for melanin by UV light absorption and intermediate products from the haem pathway 302 
by LC-MS analysis. 303 
Overall, this work is a promising proof of concept for using cell-free extracts in SMs research, which may 304 
lead to the characterisation of unknown BGCs from genome mining. However, further challenges remain 305 
in applying it to environmental strains and other classes of specialised metabolites, where less a priori 306 
knowledge is available. Nevertheless, this tool has potential for scalability that could lead to the chemical 307 
purification and characterisation of new metabolites, circumventing incompatibilities with heterologous 308 
hosts, a typical obstacle in traditional approaches [73]. 309 
 310 
Developing an endogenous quorum-sensing based CRISPRi circuit for autonomous and 311 
tuneable dynamic regulation of multiple targets in Streptomyces [53] 312 
Traditional metabolic engineering often referred to as static metabolic engineering, mainly uses two 313 
approaches to increase metabolite titres: either by deleting genes from competing pathways to force the 314 
metabolic flux into a specific pathway, or by overexpressing key enzymes through engineering promoters 315 
or ribosome binding sites [74]. However, this often results in an overall reduced strain fitness caused by 316 
metabolic imbalances due to competition around cellular resources, leading to the accumulation of 317 
certain undesired products and/or decreased growth rates. The formation of heterogenous 318 
microenvironments inside large scale bioreactors can also lead to variable performance of statically 319 
engineered strains. A comprehensive overview of the challenges can be found in Hartline et al. [75].  320 
Dynamic metabolic engineering approaches attempt to create an autonomous response based on the 321 
environmental factors or internal metabolic states. Tian et al. introduce a pathway-independent 322 
regulation using a CRISPR-based tool with integrated quorum sensing (EQCi) to regulate multiple target 323 
genes in Streptomyces. The quorum sensing component allows an autonomic and dynamic response by 324 
the strain to its environment [76]. The authors designed an EQCi circuit to respond in a density-dependent 325 
manner using a γ-butyrolactone (GBL) responsive promoter to drive dCas9 expression and a synthetic 326 
promoter to regulate the transcription of guide RNAs (gRNAs) targeting genes of interest. GBLs are well-327 
known for playing a role as regulatory molecules for antibiotic production and development in 328 
Streptomyces [77] which counteract the aforementioned challenges. 329 
The system was validated with rapamycin, a polyketide produced by S. rapamycinicus, by perturbing three 330 
key nodes in primary metabolism to shift metabolic fluxes toward enhanced rapamycin production: fatty 331 
acid (FA) synthesis, tricarboxylic acid (TCA) cycle, and aromatic amino acid (AAA), which are competing 332 
with the rapamycin biosynthetic pathway over precursor molecules such as malonyl-CoA and methyl-333 
malonyl-CoA. The EQCi-based individual repression of key genes in the TCA, FA and AAA resulted in 334 
increased rapamycin titres and had little or no effect on cell growth. Validation of the EQCi circuit was 335 
performed targeting three genes simultaneously on rapamycin production. Interestingly, the EQCi circuit 336 
harbouring the gRNA combination of three genes generated the highest titre (∼660%) of rapamycin 337 
compared to controls. Repressing the transcript levels of these target genes confirmed that they were 338 
dynamically regulated in a cell density-dependent manner. 339 
Additionally, the applicability of the EQCi circuit was demonstrated with actinorhodin, a polyketide 340 
produced by S. coelicolor [78]. Remarkably, the strain carrying the same EQCi system targeting gltA gene 341 
(sco2736) from the TCA cycle showed ∼850% more actinorhodin than the wild type [78].  342 
In summary, incorporating both the QS system and CRISPRi allows an adjustable, completely autonomous, 343 
and dynamic downregulation of single or multiple pathways leading to metabolic flux redirection, thus 344 
increasing target product biosynthesis without further interventions. However, off-target effects of the 345 
gRNAs may result in unforeseen changes in metabolic flux as various genes are silenced simultaneously. 346 
The result may be an insufficient supply of metabolites for primary metabolism and lead to growth 347 
retardation and lower production yields. Therefore, a way forward will be to conduct quantitative studies 348 
where various gRNAs are created for each gene and using sequencing to determine the best position for 349 
each gRNA for the desired level of expression. Such quantitative datasets could enable computational 350 
models for gRNA placement. Overall, this tool holds the potential to become a universal technology for 351 
other industrial microorganisms. 352 
Taken together the development of both data analysis tools to mine the ever-increasing amount of 353 
available data from genomes, transcriptomes, proteomes, and metabolomes along with the much-needed 354 
advancement of synthetic biology tools and the adaptations of genetic manipulation methodologies 355 
already available in other organisms, has improved and facilitated the study of the extensive metabolic 356 
repertoire of actinomycete. These pioneer signs of progress have a major effect on the study of SMs. The 357 
computational predictive tools and the experimental methods are intrinsically linked, as advancement in 358 
the first informs the next step of development in the second. In the following sections, we addressed the 359 
link between computational and synthetic biology approaches to understand development and regulation 360 
of specialised metabolism, and their ecological interactions.   361 
II. Specialised Metabolites 362 
Actinomycetes have evolved a complex chemical language by synthesising diverse SMs detectable by the 363 
presence of a high number of BGCs in their genomes [5]. For bioprospecting novel SMs, considerable 364 
resources have been invested in pursuing unique reservoirs and unveiling their striking features. For 365 
instance, rare actinomycete, which represent less frequently isolated genera than Streptomyces [79], have 366 
become established sources for structurally-diverse and chemically-unique SMs [80]. Special attention has 367 
also been placed into marine actinomycete, where highly-bioactive novel taxa have been described, such 368 
as Salinispora spp. [81, 82]. Furthermore, underexploited environments that drive unique evolutionary 369 
pressures have also been recently investigated, such as polar regions [83], caves [84–86], and deserts [87–370 
89]. 371 
Combining omics technology, such as genome mining and untargeted metabolomics, offer powerful 372 
means to gain insights into the natural role of SMs. One of the selected studies uses high-throughput 373 
comparative genomics of the rare genus Nocardia to reveal how variations on BGCs reflected differences 374 
in the chemical structure of the compounds [90]. We also discuss a second study where the chemical 375 
potential of rare actinomycete from unusual habitats such as polar regions is explored, linking this 376 
chemical potential to their genomic information through the novel tool NPLinker [91]. 377 
The availability of big data has encouraged the design of new mining tools for uncommon BGCs classes 378 
enabling novel insights into SMs. This is the case for our selected paper that describes one novel approach 379 
based on phylogenetic relationships and evolutionary divergence within a gene cluster to guide the 380 
subsequent experimental rationale [92]. Moreover, the chemical-reverse approach can also be 381 
informative, which takes compound elucidation as the starting point to go backwards and attempt to link 382 
its production to the responsible BGC [93]. Altogether, these different approaches increase the likelihood 383 
of discovering new BGCs to access the chemical uniqueness of their respective products, both crucial to 384 
discovering novel SMs. 385 
Comparative genomics and metabolomics in the genus Nocardia [90] 386 
A valuable approach to studying rare actinomycete relies on performing a deeper investigation of a 387 
promising genus through high-throughput comparative genomics and metabolomics of closely related 388 
species. Männle et al. applied genomic tools to predict molecules produced by BGCs and compare the 389 
findings with metabolomics data to identify chemical divergences in the structure of the compounds 390 
related to variations in the BGCs. Although still a major challenge, authors merged several data sets 391 
obtained from different technics and tools, such as antiSMASH, BiG-SCAPE, LC-MS/MS, GNPS, and NMR, 392 
by studying a conserved metabolic pathway from Nocardia strains. 393 
First, phylogenetic inferences of over 100 Nocardia genomes from diverse sources were constructed 394 
based on conserved housekeeping genes, retrieving six major clades. Correlation between BGCs 395 
abundance and the respective clades was observed, and BGCs diversity was further investigated by 396 
applying BiG-SCAPE. As several GCFs were widespread in Nocardia genomes, authors focused on a 397 
conserved cluster predicted to produce nocobactin-like siderophores. Strict adjustment of BiG-SCAPE 398 
threshold similarity parameters resulted in the formation of gene clusters subfamilies. Thus, it was 399 
possible to observe that each subfamily of clusters had divergence in their metabolic pathway genes. 400 
Compounds biosynthesized by the BGCs of these subfamilies were predicted, and 12 Nocardia strains 401 
were cultivated to analyse their metabolomics profile through LC-MS/MS.  402 
Furthermore, a molecular network was constructed using the GNPS platform, and correlated with the 403 
GCFs network. Analysis of detected ions led to the identification of nocobactin-like compounds based on 404 
fragmentation patterns and NMR data. These experimental results supported the bioinformatic 405 
predictions, allowing the assignment of BGC candidates to derivatives of known compounds. Also, a 406 
Nocardia strain was identified that might produce previously undescribed nocobactin variants. 407 
Although the authors successfully correlated the prediction and identification of various nocobactin-type 408 
compounds, they could not detect these molecules from two Nocardia species that bear the biosynthetic 409 
capacity (i.e., N. araoensis NBRC 100135 and N. takedensis NBRC 100417). Instead, they discovered that 410 
these strains produce mycobactins, which leaves room for further research. This study is a promising 411 
example of developing the genomic-driven discovery of new compounds in conserved biosynthetic 412 
pathways. It demonstrates that through computational predictions and wet-lab experiments, BGCs 413 
investigation by similarity networks can predict structural variations in SMs.  414 
Comparative metabologenomics analysis of polar Actinomycetes [91] 415 
Although computational networking approaches such as GNPS and BiG-SCAPE are widely used tools for 416 
large-scale metabolomics and BGCs data analyses, respectively, the importance of linking these datasets 417 
is just beginning to be recognized [94]. In this sense, Soldatou et al. applied the novel platform NPLinker 418 
[95], an unsupervised method for integrating paired omics data, to establish links between complex 419 
metabolomics and genomics datasets relating to marine polar actinomycetes [91]. 420 
In a previous report, authors’ investigated the diversity of strains in marine sediments from the Arctic and 421 
Antarctic using culturable and metagenomics approaches, which leads to a collection of 50 actinomycete 422 
strains [83]. Soldatou et al. went a step further into exploring the chemical potential of twenty-five strains 423 
of these phylogenetically and geographically diverse polar rare actinomycetes. In an attempt to discover 424 
chemical diversity, underexplored genera -in comparison to Streptomyces [79]- were selected, including 425 
Pseudonocardia spp., Micrococcus spp., Rhodococcus spp., and Microbacterium spp. By applying the one 426 
strain many compounds approach (OSMAC), a collection of 100 extracts was produced and analysed via 427 
LC-MS/MS. Then, the distribution of parent ions as an equivalent of detected metabolites was correlated 428 
to bioactivity against ESKAPE pathogens. However, it was found that bioactivity was not necessarily 429 
related to the highest number of parent ions. A molecular networking analysis, which included the 430 
MolNetEnhancer workflow [96], was carried out to assess the chemical diversity and cluster the paired 431 
ions into MFs. 432 
Additionally, genome mining for 17 strains sequenced by Illumina technology revealed a total of 133 BGCs, 433 
where 67% showed none or low homology to the MIBiG repository [97], suggesting novelty on the 434 
biosynthetic potential of the analysed strains. After clustering the BGCs into GCFs using BiG-SCAPE, 435 
NPLinker was used to suggest potential links between GCFs and MFs based on two standardised scoring 436 
functions. This approach made it possible to predict four metabolites, including the known compounds 437 
ectoine and chloramphenicol, whose experimental validation awaits to be confirmed.             438 
Soldatou et al. show how the study of phylogenetically diverse polar actinomycetes can lead to the 439 
discovery of novel chemistry. For instance, marine Pseudonocardia and Rhodococcus strains were 440 
identified as potential sources of bioactive metabolites for further studies. Despite their interesting 441 
bioactivity profile, Pseudonocardia strains were excluded from the genomic analysis due to difficulties in 442 
assembling a complete genome from short reads, which would be interesting to cover in future.  443 
Although one of the major limitations of the metabologenomic approach was the relatively low number 444 
of publicly available experimental datasets, the proposed methodology proved to be an effective tool for 445 
strain prioritisation, thus constituting a promising strategy for accelerating the discovery of novel 446 
chemistry derived SMs. Undoubtedly, further integration of bioactivity with the paired omics data will 447 
strengthen the possibility of identifying strains capable of producing new chemistry in future culture 448 
collection screenings. 449 
Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling [92] 450 
Big data analyses can be overwhelming, and thus prioritisation of BGCs to guide SMs discovery remains a 451 
continuous challenge. One strategy to accomplish BGCs selection is phylogeny-guided, as biosynthetic 452 
genes that diverge during evolution may produce compounds with new biological activity. An interesting 453 
example was demonstrated for glycopeptide family (GPAs) antibiotics, where phylogenetic reconciliation 454 
allowed us understand their origin and evolution [98]. Culp et al. investigate GPAs evolutionary dynamics 455 
by constructing a phylogenetic analysis of all shared genes from BGCs of GPAs and highlighting the 456 
evolutionary divergences observed in NRPS condensation domains [92]. Data were correlated with the 457 
presence/absence of self-resistance genes, which unveiled that BGCs with resistance determinants are 458 
commonly present in true GPAs and grouped into a single clade. Interestingly, two additional clades 459 
lacking known GPA resistance genes were further studied: while one was found to be related to a known 460 
compound called complestatin; the other had no associated molecule, leading to the isolation and 461 
identification of a new compound, carbomycin. 462 
 463 
Both compounds, complestatin and carbomycin, were experimentally demonstrated to be members of 464 
the GPA family active against Gram-positive bacteria, including the vancomycin-resistant Enterococcus sp. 465 
and other drug-resistant clinical strains. Moreover, the mechanism of action of these compounds was 466 
described for the first time, showing they bind to peptidoglycan and block the autolysins enzyme action 467 
that is essential for cell wall remodelling. These enzymes are responsible for peptidoglycan cleavage 468 
during cell division and have a role in cell wall turnover [99]. Hence, blocking these enzymes results in 469 
bacterial growth inhibition. In addition, despite attempts to select resistant mutants to both complestatin 470 
and carbomycin compounds, resistance evolved slowly on the tested bacteria. Finally, topical lotions 471 
containing both compounds were developed and tested in vivo against superficial infections in mice skin, 472 
where it also was found to be effective in reducing bacterial growth. 473 
Overall, this study demonstrates the potential of analysing BGCS evolutionary divergences for aiding and 474 
guiding cluster prioritisation. When combined with the analysis of resistance determinants of a specific 475 
antibiotic class, it can lead to discovering new compounds and novel mechanisms of action, contributing 476 
to the advancement in the treatment of drug-resistant infections. Nevertheless, dealing with a novel 477 
mode of action needs further investigation in the steps that are being blocked at the molecular level, 478 
making the investigation even more challenging. However, this study stands as a light of hope to face the 479 
rediscovery problem, not only due to the delivery of a novel antibiotic but also, elucidating modes of 480 
action.   481 
A biaryl-linked tripeptide from Planomonospora reveals a widespread class of minimal RiPP 482 
gene clusters [93] 483 
RiPPs have drawn attention due to their intricate three-dimensional structures and broad distribution 484 
across actinomycete [20]. RIPPs BGCs encompass a gene encoding the precursor peptide and genes 485 
encoding enzymes that modify that peptide. The precursor peptide is ribosomally synthetised, modified 486 
by enzymes included in the corresponding RIPP BGCs and activated by cleavage of the N-terminal leader 487 
peptide from the C-terminal core peptide [100]. Zdouc et al. discovered the smallest coding gene 488 
described to date, belonging to a new class of RiPPs minimal BGCS which remained undetected using well-489 
established software pipelines. 490 
Stemming from metabolomic studies of Planomonospora strains from Naicons’ strain collection [101], 491 
Zdouc et al. purified and elucidated the structure of a novel tripeptide with an unusual carbon-carbon (C-492 
C) bond between amino acids. The authors propose to call this novel class of compounds biarylitides, since 493 
the products feature a C-C bridge between the aromatic amino acid residues. The gene cluster responsible 494 
for such a product could not be identified using the antiSMASH platform, so a tailored approach was 495 
needed to unveil the region coding for enzymes that produce biarylitides. Heterologous expression proved 496 
that a minimal gene cluster consisting of only two genes is sufficient to the develop the mature product 497 
in a heterologous Streptomyces host. Biosynthesis was described as follows: first, the pentapeptide 498 
precursor is ribosomally synthesized from the smallest gene ever to be described, bytA, accounting for 499 
solely 18-base pairs. Then, the C-C bond between the aromatic moieties of the third and fifth amino acid 500 
is carried out by bytO, coding for a cytochrome P450 monooxygenase. The cleavage of the two leading 501 
amino acids and N-acetylation of the mature product are likely to be carried out by other enzymes from 502 
central metabolism.  503 
Surprisingly, bioinformatic analysis of 3,300 genome sequences revealed that the class of minimal RiPP 504 
clusters described by Zdouc et al. are widely distributed across various actinomycete genera. However, 505 
the biological role of this BGC and the product remains to be understood, as well as its applicability. 506 
Investigating the mechanism and specificity of the biaryl crosslink might have important uses in stabilizing 507 
peptides for different applications. This study highlights the importance of metabolomics-guided studies 508 
in discovering novel BGC types, without the need for including bioactivity assays in the metabolite 509 
prioritisation step to purify and describe an interesting compound.  Undoubtedly, this study highlights the 510 
usefulness of additional approaches for BGCs discovery alongside traditional genome mining tools, which 511 
simply cannot predict unprecedented BGCs. Furthermore, this opens the road for their future 512 
evolutionary and comparative genomic study.  513 
 514 
Overall, these studies stand as solid examples of how integrating genomics and metabolomics data 515 
analyses can provide unique insights that otherwise remain hidden when datasets are analysed 516 
independently. Regarding rare actinomycetes, unique environments or not-so-common classes of 517 
compounds like RiPPs or GPAs, are examples of how unconventional approaches may unveil new 518 
opportunities for discover novel compounds. Moreover, the study of SMs needs to be considered as a 519 
whole, understanding that while they might be important in the clinical setting, their primordial role 520 
probably relies on a fundamental metabolic function within bacteria, which can be revealed through the 521 
understanding of actinomycete’s complex development, which will be discussed in the next section.  522 
III. Development and Regulation 523 
Unlike other bacteria, filamentous actinomycetes such as Streptomyces, possess a strikingly complex life 524 
cycle. Briefly, a germinating spore establishes a multicellular network of vegetative mycelium by growing 525 
through hyphal tip extension and branching. After depletion of nutrients, it undergoes autolytic 526 
degradation forming aerial hyphae followed by segmentation into spore chains that will spread to start a 527 
new developmental cycle [102]. Phenotypic differentiation also leads to genetic heterogeneity due to the 528 
high-frequency of rearrangements and deletions [103]. Although this phenomenon was known a time ago, 529 
one of the studies selected for this review linked this phenotypic differentiation to a division of labour 530 
within Streptomyces colonies, giving rise to enhanced capacity of antibiotic production [104]. 531 
SMs production is also correlated with Streptomyces morphogenesis at the onset of sporulation, being 532 
another evidence of how stress and developmental programmes are intimately connected [105]. Master 533 
regulators, such as Bld (aerial hyphae formation) and Whi (spore formation) are amongst the molecular 534 
mechanisms governing development, involving complex regulatory cascades [106–108]. Additionally, 535 
nucleotide second messengers, such as p(p)ppGpp, cAMP, c-di-AMP and bis-(3´,5´)-cyclic di-guanosine 536 
monophosphate (c-di-GMP), play a major role in coordinating the transition between vegetative 537 
filamentous hyphae growth, reproductive aerial mycelium, and subsequent differentiation into spore 538 
chains [109]. Recently, transcriptional profiles of hyper-sporulating and delayed-development mutants 539 
revealed novel key genes responsive to c-di-GMP dynamics [110], discussed in another article we selected. 540 
Ultimately, to understand the complex regulation of the life cycle of actinomycetes is paramount to take 541 
advantage of the full potential of these antibiotic-producers’ organisms. Moreover, this may be 542 
considerably improved with a better understanding of the basic underlying regulatory mechanisms, an 543 
area where further study is needed. 544 
Antibiotic production in Streptomyces is organized by a division of labor through terminal 545 
genomic differentiation [104] 546 
Although the phenomenon of genomic instability was discovered in Streptomyces decades ago [111], it 547 
has remained poorly understood. Zhang et al. describe how this genetic diversification is intertwined with 548 
a division of labour in Streptomyces colonies, causing irreversible differentiation that gives rise to mutants 549 
with enhanced antibiotic production capabilities. 550 
In colonies starting from a single spore, up to 2% of cells, depending on media and growth conditions, 551 
undergo vast genetic rearrangements found on both chromosomal ends that lead to an increase in 552 
antibiotic production. Genome rearrangements can vary in size and frequency, while deletions can cause 553 
a loss of up to 1,000 genes; amplification of regions also occurs, containing various gene copies flanked 554 
by an insertion sequence (i.e., IS1649, encoded by SCO0091 and SCO0368). While each mutant has a 555 
unique profile of inhibition against other soil-dwelling competitors, their ability to form spores becomes 556 
greatly hampered. Moreover, through these specialised mutants, the parent strain gains an advantage by 557 
maximising both the colony-wide antibiotic production and its diversity. 558 
The link between genomic instability and phenotypic heterogeneity was established by sequencing 559 
morphologically distinct daughter colonies of S. coelicolor M145. Instead of reverting their morphology 560 
back to wild type, as would be expected in the case of a clonal population, the progeny of aberrant 561 
colonies was hypervariable. Sequencing revealed that mutants contained profound chromosomal 562 
changes, involving insertions and deletions, from both arms of the chromosome. In addition, the authors 563 
established an elegant method for deducing the minimal deletion size from phenotype, by linking arginine 564 
auxotrophy and chloramphenicol susceptibility, by using pulse field gel electrophoresis (PFGE). 565 
Furthermore, pigmented antibiotics from S. coelicolor M145 were used as indicators of bioactivity, 566 
confirmed by overlay assays against Bacillus subtilis. Additional experiments of mixing spores from wild 567 
type and mutant colonies in known proportions showed a strong positive correlation between the 568 
percentage of mutants in the starting population and the inhibition zone size. When measuring the overall 569 
spore count of such mixed colonies, no significant reduction was observed until mutants comprised up to 570 
50% of the starting population, thereby neutralising the high individual fitness cost for the colony. 571 
Interestingly, the final frequency of mutant spores declined to less than 1%, even if the starting proportion 572 
was as high as 80%. In the future, it will be interesting to see if this phenomenon is also true for non-573 
pigmented antibiotics.  574 
The work of Zhang et al. shows that Streptomyces colonies starting from a single spore become genetically 575 
diverse with daughter cells specialising in specific tasks, thus providing for the first-time evidence of 576 
division of labour in antibiotic production and spore formation. The molecular mechanisms regulating 577 
these rearrangements remain to be discovered. Furthermore, it would be relevant to understand the cues 578 
triggering these rearrangements for the manipulation of antibiotic producing strains, as they might 579 
depend on external signals and/or be context dependant. We are looking forward to follow-up studies as 580 
preliminary results on Streptomyces environmental isolates hint towards a widespread nature of such 581 
division of labour. 582 
Specialized and shared functions of diguanylate cyclases and phosphodiesterases in 583 
Streptomyces development [110] 584 
In Streptomyces, c-di-GMP is a key life cycle regulatory factor [112] that coordinates cell-fate via a complex 585 
signalling network: while BldD-(c-di-GMP) acts as a transcriptional regulator of vegetative filamentous 586 
growth [113]; initiation of sporulation is determined by the activity of the σWhiG RsiG-(c-di-GMP) complex 587 
[114].Turnover of the second messenger c-di-GMP is mediated by two sets of enzymes with specific 588 
catalytic domains [115]: diguanylate cyclases (DGCs) that catalyse its synthesis, and phosphodiesterases 589 
(PDEs) that are involved in its degradation [116].  590 
Although c-di-GMP-sensors are known, there is a gap in understanding which genes are responsive to c-591 
di-GMP dynamics. Haist et al. aimed to unveil the specific molecular targets in two DGCs mutants (ΔcdgB 592 
and ΔcdgC) driving hyper-sporulation, and two PDEs mutants (ΔrmdA and ΔrmdB) delaying development 593 
[115]. RNA-seq was used to compare mutants' transcriptional profiles with wild type S. venezuelae, and 594 
further biochemical experiments were developed to confirm the function of the differentially expressed 595 
genes.  596 
Results demonstrate that c-di-GMP has a global regulatory role, antagonistically controlled by the DGCs 597 
(CdgB and CdgC) and the PDEs (RmdA and RmdB). Despite observing shared enzymatic activities between 598 
the two DGCs and the two PDEs, respectively; each one controls a characteristic set of genes, representing 599 
unique roles in developmental regulation and thus explaining their differential phenotypes. Unexpectedly, 600 
few bld and whi genes, known to be key regulators of the developmental regulatory cascade, were 601 
differentially expressed in the mutant strains. On the contrary, two other categories were significantly 602 
affected: the expression of the hydrophobic sheath, controlled via chaplin (chp) and rodlin (rdl) genes; 603 
and the cell division components, through ftsZ expression. 604 
Overall, Haist et al. demonstrate how PDEs (RmdA and RmdB), and DGCs (CdgB and CdgC) differentially 605 
govern development via transcriptional BldD and σWhiG fine-tuned sensing of c-di-GMP, contributing to 606 
our understanding of the c-di-GMP multilayered cascade. In addition, expression of c-di-GMP-responsive 607 
genes revealed insights into how they involved in the coordinated progression of Streptomyces’ life cycle. 608 
While cell division genes control the specific timing of when spores are formed, such as ftsZ; the 609 
determination of the sporulation mode, either being in the aerial hyphae or out of substrate mycelium, is 610 
induced through chaplin and rodlin genes, which are involved in the formation of the hydrophobic sheath 611 
that cover aerial hyphae and thus control where spores are developed.   612 
Furthermore, a link between c-di-GMP signals and antibiotic genes expression was proposed, by studying 613 
of the chloramphenicol pathway. Chloramphenicol BGC involves 17 cml genes [117], which were 614 
significantly downregulated in the two mutants driving hyper-sporulation through the repression of bldM. 615 
However, cml genes were not observed affected in the two delayed-development mutants. Recently, the 616 
modulation of c-di-GMP has demonstrated to be an appealing candidate to manipulate antibiotic 617 
production [118]. Thus, expanding how c-di-GMP affects other antibiotic pathways, along with the effect 618 
on c-di-GMP-responsive genes remains for further investigation.   619 
 620 
Understanding the complex regulatory networks that underlie the developmental life cycle is crucial to 621 
uncover the full potential of these producer organisms. These studies show that it is fundamental to gain 622 
knowledge into the molecular effectors that can trigger SMs synthesis. These insights can subsequently 623 
inform metabolic engineering strategies for improved antibiotic production. Furthermore, in addition to 624 
the internal regulation of SMs synthesis, biotic and abiotic environmental cues can also trigger the 625 
activation of certain BGCs, leading us into the final section of this review where we focus on ecology and 626 
host interactions. Deciphering actinomycete interactions either with other micro- and/or macro- 627 
organisms will increase the understanding on how SMs act as signalling compounds. Moreover, a better 628 
knowledge of interspecies interactions will further unlock the huge chemical diversity of actinomycete 629 
SMs. Altogether, it is becoming clear that a deep understanding of all intra- and extra-cellular factors 630 
affecting BGCs expression and SMs biosynthesis are necessary to further our comprehension into 631 
actinomycete research.   632 
IV. Ecology and Host Interactions 633 
Although actinomycete are well-known as antibiotic producers, most BGCs remain silent in controlled 634 
conditions [38, 102]. There is little ecological rationale for the constitutive production of these 635 
energetically expensive metabolites when grown in favourable conditions such as high nutrient media. 636 
Moreover, SMs production is generally under strict regulatory control, meaning that several cues 637 
triggering BGCs expression can be absent or even repressed [119, 120]. However, in nature, actinomycete 638 
are part of complex microbial communities and globally there is a lack of understanding of these 639 
community dynamics. Additionally, actinomycete are ubiquitous in several habitats, facing ecological 640 
adaptations that affect genetic determinants expression. Identifying ecologically relevant interactions is 641 
further complicated when symbiosis with macro-organisms such as plants, fungi and animals is 642 
considered. Overall, these interactions control the expression of actinomycete BGCs, which in turn, and 643 
have played a major role in the evolution of the vast chemical diversity of SMs [121]. Co-culture 644 
experiments attempt to mimic these complex relationships in the laboratory and thus elicit the production 645 
of SMs [11]. Therefore, we selected one article where the co-culture approach of Salinispora tropica with 646 
phytoplankton led to the decryption of two BGCs [122].  647 
In soil, Streptomyces species are free-living bacteria that play an important role in decomposing of organic 648 
matter by breaking down complex materials [10]. Geosmin is a widespread metabolite known long ago as 649 
the responsible for conferring Streptomyces their earthy odour. However, until now, the ecological role 650 
of geosmin was cryptic. A highlight from 2020 was that first insights into geosmin role in nature were 651 
uncovered, by an article we selected that demonstrate how geosmin production is closely linked to 652 
Streptomyces developmental cycle, where is shown that geosmin is used to attract springtails that help to 653 
disperse bacterial spores over longer distances [123]. 654 
Additionally, actinomycete have been recognized as defensive symbionts of several invertebrate species 655 
[124]. They have been shown to interact with plant roots, where they have evolved beneficial interaction 656 
for protection against phytopathogens [121]. For example, Streptomyces can enter the root tissue and 657 
enable plants to compete for food by enhancing root exudates [10]. Moreover, they can exert plant 658 
growth-promoting (PGP) activities, by increasing plant biomass through direct or indirect manners, such 659 
as phosphate mobilization, nitrogen fixation, iron acquisition, or enhancing the production of plant 660 
hormones, to name just a few [125]. The study we have selected highlights the potential of Streptomyces 661 
as plant probiotics in Arabidopsis thaliana, which can further be applied to commercial crops [126]. 662 
Altogether, these important interactions reflect the natural purpose of harbouring a large repertoire of 663 
chemical diversity and how these SMs have evolved as a direct product of these interactions.  664 
 665 
Phytoplankton trigger the production of cryptic metabolites in the marine actinobacterium 666 
Salinispora tropica [122] 667 
Antagonistic interactions between the marine-obligate Salinispora tropica and co-occurring heterotroph 668 
bacteria have been previously reported [127]. The induction of antibiotic activities has been linked to 669 
temporal changes in compound production composition through a complex pattern that varies regarding 670 
the interaction and type of metabolites [128]. Chhun et al. extend this co-culturing approach by adding 671 
insights into inter-species interactions between S. tropica and marine phototrophs. Through the 672 
integration of co-culture, metabolomics and proteomic techniques, phototrophs' effect on Salinispora 673 
BGCs expression is investigated. 674 
Chhun et al. reported that S. tropica CNB-440 affects the growth of a taxonomically diverse group of 675 
phytoplankton which includes the model species Synechococcus sp. WH7803 (cyanobacteria); Emiliania 676 
huxleyi (coccolithophore); and Phaeodactylum tricornutum (diatom). A co-culture experiment using a 677 
porous membrane to separate the organisms physically suggested that secreted metabolites of S. tropica 678 
importantly affected Synechococcus sp. proliferation. Furthermore, metabolomic analyses of co-cultures 679 
of S. tropica and Synechococcus sp. revealed the production of eight metabolites that were not detected 680 
in axenic culture: four were related to the known compound salinosporamide, whilst the other four were 681 
identified as potentially novel. As an attempt to identify BGCs overexpressed in the phototroph co-culture, 682 
a comparative proteomic analysis was carried out with the proteome of S. tropica exposed to 683 
phytoplankton photosynthate (i.e., Synechococcus culture supernatant, rich in phototroph-released 684 
nutrients). Besides confirming salinosporamide’s BGCS (sal) overexpression, several proteins encoded in 685 
orphan BGCs were detected in the photosynthate culture. A polyketide synthase (pks3) and a non-686 
ribosomal peptide synthetase (nrps1) cluster were identified as putatively responsible for metabolite 687 
biosynthesis. 688 
Chhun et al. illustrate the importance of an integrative approach in the study of actinomycete ecology. It 689 
was demonstrated that metabolites produced by the rare actinomyces marine S. tropica CNB-440 have 690 
the potential to kill both prokaryote and eukaryote phytoplankton. Although the experimental model may 691 
not represent exactly the ecological interactions found in the ocean, the photosynthate cultures are a 692 
good approximation to test the effect of phytoplankton over the expression of BGCs in Salinispora. 693 
Moreover, it was shown that co-culturing phototrophs and marine-derived actinomycete could accelerate 694 
the discovery of novel bioactive metabolites. Metabolomics analysis was used to identify the 695 
overexpressed metabolites in co-cultures, allowing the identification of four putative candidates. 696 
Metabolites potentially encoded in nrps1 and elicited by photosynthate showed promising antimicrobial 697 
activity. Unfortunately, it was not possible to link a particular overexpressed metabolite with this BGCS, 698 
thus awaiting further identification. Besides expanding the knowledge on the specialised metabolites 699 
produced by Salinispora, this study provides new insights into the ecology of actinomycete in marine 700 
environments.  701 
Developmentally regulated volatiles geosmin and 2-methylisoborneol attract a soil arthropod 702 
to Streptomyces bacteria promoting spore dispersal [123] 703 
Geosmin is a sesquiterpenoid metabolite known for giving soil its characteristic earthy-smelling odour, 704 
produced by several actinomycete [129], amongst other microorganisms. Its biosynthesis involves a 705 
geosmin synthase, which catalyses the cyclization of farnesyl diphosphate to germacrene D and 706 
germacradienol, and then converts the latter to geosmin [130]. Interestingly, genes for its biosynthesis 707 
are highly conserved in all Streptomyces genomes [131]. Similarly, genes for the biosynthesis of another 708 
earthly-smell molecule, the monoterpene 2-methylisoborneol (2-MIB), are found in approximately half of 709 
sequenced Streptomyces genomes [131]. The ubiquity of producing these volatile organic compounds 710 
(VOC) in streptomycetes suggests that they confer a selective advantage. However, the benefit for the 711 
producer bacteria and, therefore, geosmin’s biological role remained unknown. 712 
Becher et al. investigated the role of VOCs in the context of Streptomyces interaction with soil-dwelling 713 
arthropods, the springtails. In field experiments, springtails showed a significant attraction to traps baited 714 
with Streptomyces coelicolor colonies, further confirmed in laboratory Y-tube bioassay. Chemosensory 715 
responses in springtail antennae gas chromatography (GC) combined with electrophysiological antennal 716 
detection (EAD) revealed that geosmin, germacradienol, germacrene D, and 2-MIB induce sensory 717 
responses. Mutants of these VOCs (ΔgeoA; ΔmibAB; and ΔgeoA ΔmibAB double mutant) demonstrated 718 
that both earthy odorants are behaviourally active and serve as attractants for the springtail, guiding them 719 
for localization of food sources. 720 
Transcriptome analyses unveil that these VOCs are intimately connected to Streptomyces developmental 721 
life cycle. Expression of geoA and mibA-mibB depends on the regulatory gene bldM, involved in aerial 722 
hyphae and spore’s development [132], further confirmed by lack of production of geosmin and 2-MIB in 723 
a ΔbldM mutant. Interestingly, mibA-mibB genes were found to form an operon with eshA, encoding for 724 
a cyclic nucleotide-binding protein of unclear function, which remains to be characterised. ChIP-seq 725 
showed that BldM directly regulates the eshA-mibA-mibB promoter; however, it does not regulate geoA 726 
which instead is directly regulated by WhiH, involved in correct septation of aerial hyphae during spore 727 
formation [133].The production of both earthy odorants is directly coupled with spore formation via 728 
transcriptional control of key sporulation regulators. 729 
The geosmin- and 2-MIB-mediated attraction of springtails and the correlation of these VOCs to spore 730 
formation suggested that springtails might act as vectors for spore dispersal. Authors confirmed this 731 
observation by demonstrating that it occurs via two different routes: adherence to their body surface 732 
cuticle; and passage through the gastrointestinal tract and defecation. Therefore, Streptomyces benefit 733 
from emitting geosmin and 2-MIB as part of their developmental programme as these volatile scents guide 734 
springtails to sporulating microcolonies, where they serve as vectors for spore dispersal over long 735 
distances. It remains to be discovered if this relation can be also observed in another soil insects or even 736 
more, expanded to other co-inhabiting animals. Further research is needed to test Streptomyces-737 
springtails interaction in a community context, and to explore the role of other VOCs may act as either 738 
attractants or repellents for a comprehensive understanding of chemical ecological complex interactions.  739 
Streptomyces endophytes promote host health and enhance growth across plant species 740 
[126] 741 
Streptomyces have been previously reported to interact with plant roots either through the rhizosphere, 742 
which is the root surrounding soil; or the endophytic compartment, the niche within and between root 743 
cells [125, 134]. Recent studies in Arabidopsis thaliana have revealed that streptomycetes are present and 744 
enriched in the endophytic compartment relative to that in the bulk soil [135, 136]. Streptomycetes have 745 
also been isolated from the endophytic compartment of numerous other plant species, including crops. 746 
Taking together, both the ability of Streptomyces to colonize plant roots along with the extensive 747 
repertoire of SMs, makes them interesting candidates for biocontrol in crops, with a possible application 748 
as plant probiotics. To this end, Worsley et al. isolated Streptomyces endophytes from A. thaliana roots 749 
to test the hypothesis of beneficial effects on the host and test these strains on commercial crops plants, 750 
such as wheat.  751 
Five strains were isolated from A. thaliana root microbiome (i.e., L2, N1, N2, M2 and M3) and compared 752 
to another three strains of the known endophyte Streptomyces lydicus, all selected for genome 753 
sequencing. First, eGFP-tagged Streptomyces strains were re-infected into A. thaliana roots to verify the 754 
ability of the endophyte to recolonise plants. Then, all the genome-sequenced strains were inoculated 755 
into seedlings to investigate their effect on growth. It was observed that strains were able to colonize the 756 
root surface, having a significant effect on plant biomass: strains L2, M2, and M3 gave the best 757 
enhancement of dry biomass, while the three S. lydicus strains had no effect. Moreover, strains N1 and 758 
N2 decreased A. thaliana growth. Interestingly, plant-treated with a mixture of L2, M2, and M3 gave 759 
higher growth in comparison with individual and uninoculated controls, respectively.  760 
Genome mining and bioassays of all the eight sequenced strains revealed that they produce PGP 761 
compounds, including indole-3-acetic acid (IAA) and ACC deaminase. Moreover, they possess several BGCs 762 
involved in siderophores and antimicrobial compounds. Among them, strain N2 shows a broad-spectrum 763 
antimicrobial activity and produces filipin-like polyenes, including 14-hydroxyisochainin. N2 antifungal 764 
activity was improved 2-fold in the presence of IAA, suggesting that N2 may display its activity in proximity 765 
to the plant root when competing with other microbes. Additionally, coating wheat seed with N2 protects 766 
the germinating seedlings from the take-all fungus Gaeumannomyces graminis var. tritici, an economically 767 
important wheat pathogen. 768 
In summary, this study demonstrated that introducing certain Streptomyces into the root microbiome 769 
provides significant benefits to host plants. However, two of the five root-associated Streptomyces strains 770 
showed a negative in vitro effect regarding A. thaliana’s biomass. Therefore, the effects of Streptomyces 771 
strains on host plants seem to be strain-dependent, and further research is needed to understand their 772 
role in these interactions. Nevertheless, the authors achieve to develop a system for studying the role of 773 
SMs in nature that may provide new insights to activate silent BGCs. Specifically, they demonstrate that 774 
IAA increased the antifungal activity of one of the root-associated Streptomyces strains, providing 775 
evidence of how external signals can affect the expression of SMs. In addition, exploring plant-776 
Streptomyces interactions led to the identification of novel PGP and biocontrol agents that could be 777 
developed as active biofertilizers, as greener alternatives to pesticides currently having a negative impact 778 
in ecosystems. In future, it will be interesting to expand the testing and explore the effects of 779 
Streptomyces in other crops.  780 
Concluding Remarks 781 
This review highlights recent research that uses integration of perspectives to further understand 782 
actinomycete biology, focusing on four broad areas: i) technology and methodology; ii) specialised 783 
metabolites; iii) development and regulation; and iv) ecology and host interactions.  784 
In the last decade, the genomic era opened a new roadmap for the study of SMs in actinomycetes. The 785 
accessible cost of whole-genome sequencing enabled the exploration of not only few, but whole 786 
collections of strains. Over a relatively short period of time, the amount of available genomic data 787 
increased exponentially and is bound to continue. Likewise, other omics technologies such as 788 
metabolomics and transcriptomics have experienced a similar data expansion. Consequently, it is no 789 
surprise that efforts are focused on developing computational tools to handle this big data. BiG-SLiCE and 790 
BiG-FAM have recently expanded the BiG-SCAPE family, enabling to compare millions of BGCs, and group 791 
them into gene cluster families. Moreover, additional tools such as Qemistree, which allows hierarchical 792 
tree clustering based on chemical similarity; and NPLinker, that link both genomic and metabolomic data, 793 
permits actinomycete research to approach old problems from a different angle, such as the rediscovery 794 
of known compounds as well as prioritisation of novel BGCs.  795 
In parallel to computational advances, synthetic biology tools such as a Streptomyces tailored cell-free 796 
toolkit; and the combination of CRISPR technology with quorum sensing as a means for metabolic 797 
engineering, are crucial to test the prediction-based hypotheses using wet-lab experiments. These 798 
approaches will continue to increase our understanding of the role of newly characterised BGCs. This 799 
information can then be stored in a database such as MIBiG, which will increase our ability to conduct 800 
robust comparative studies. Additionally, synthetic biology will be a key to access silent or cryptic BGCs as 801 
well as those that are found in unculturable organisms by providing controlled conditions. 802 
The importance of applying these latest cutting-edge technologies to fundamental actinomycete research 803 
questions has already been revealed through various major findings. This review covering just over a year 804 
of research in this field offers plenty of examples such as genomic differentiation as means to achieve 805 
division of labour for antibiotic production in Streptomyces colonies; a deeper understanding of the c-di-806 
GMP regulatory cascade and the role of the enzymes involved; the use of metabologenomics focussing 807 
on a diverse phylogenetic group from polar regions and in the rare genus Nocardia, leading to the 808 
discovery of new compounds; or using evolutionary divergence in gene clusters for prioritisation of 809 
interesting BGCs, as well as the reverse approach starting from the structure of a novel metabolite to find 810 
the gene cluster responsible for its production. Finally, we also highlight the impact on ecological research, 811 
particularly how co-culturing can lead to the production of previously silent metabolites; how 812 
Streptomyces can boost plant health; and discovering the environmental role of the widely distributed 813 
geosmin.  814 
The emergence of the SARS-CoV2 global pandemic has recently put microbiology research at the heart of 815 
finding solutions for global challenges. Microbiology research will play a key role not only during the 816 
current difficult times but also in tackling future pandemics and alleviating the devastating effects the 817 
climate crisis will bring. Another major emergency in the making is the ever-increasing levels of drug 818 
resistance. Thus, our community needs to rationally exploit the potential for discovering new compounds 819 
harboured by our beloved actinomycetes and unveiling their many other secrets. Our unprecedented 820 
times reflect the need for us to act as one community, collaborate by interconnecting and overlapping 821 
knowledge from different research fields, and ultimately integrate them into shared solutions for common 822 
problems. We hope that you can see the parallels on how integrating perspectives in the actinomycete 823 
field has led to new discoveries and that there is a motivation for this to continue as a driving force in the 824 
future of actinomycete research and more widely within microbiology.   825 
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Figure Legends 843 
Figure 1. Integrating Perspectives in actinomycete research is accomplished by using a variety of different 844 
tools covering the four research areas: Development and Regulation (DR, blue); Specialised Metabolites 845 
(SM, orange); Technology and Methodology (TM, grey); and Ecology & Host Interactions (EH, yellow). The 846 
colour coding is based on selected publications covered in this review. 847 
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